Latest filing published 09 Aug 2021 for Biora Therapeutics, INC., €39k.
Insider track record
Troy Seelye: trading record in brief
Troy Seelye (senior executive) discloses dealings in Biora Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 October 2020 to 6 August 2021, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 9 August 2021: a share grant of €39k, in Biora Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Troy Seelye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,673 shares@ US$1.9491.2% of flowCommon StockSEC:0000899243-21-032278:0
- 1,925 shares@ US$2.368.8% of flowCommon StockSEC:0000899243-21-019675:0
- 54,836 shares0Common StockSEC:0000899243-21-016320:0
- 6,231 shares@ US$3.41Common StockSEC:0000899243-21-016320:1
- 14,493 shares0Common StockSEC:0000899243-20-028651:0
5 of 5 declarations